Latest news
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - KaryopharmKaryopharm · Mon, 03 Aug 2026 20:05:15 GMTWeekly Recap: XPORT-EC-042 misses PFS endpoint and SENTRY sNDA reports SVR35 - TradingViewTradingView · Mon, 03 Aug 2026 11:33:04 GMTMarket Movers | Winners: FWAC, REPL, MGRX | Losers: KPTI, BIOA, MBRX - TrefisTrefis · Mon, 03 Aug 2026 06:16:41 GMTKPTI Aug 2026 5.000 put (KPTI260821P00005000) stock price, news, quote and history - uk.finance.yahoo.comuk.finance.yahoo.com · Sun, 02 Aug 2026 17:03:29 GMTKPTI Maintained by Piper Sandler -- Price Target Lowered to $7.0 - GuruFocusGuruFocus · Sat, 01 Aug 2026 05:48:45 GMTJefferies Initiates Karyopharm Therapeutics(KPTI.US) With Buy Rating, Announces Target Price $11 - MoomooMoomoo · Fri, 31 Jul 2026 15:31:00 GMT$KPTI stock is down 67% today. Here's what we see in our data. - Quiver QuantitativeQuiver Quantitative · Fri, 31 Jul 2026 14:58:00 GMTKPTI Looks 18.2% Overvalued on GF Value™ Amid Unprofitable Statu - GuruFocusGuruFocus · Fri, 31 Jul 2026 13:09:20 GMT